Teva Plans Action After Losing Opioids Trial In New York
Israeli Firm Is Preparing ‘Swift’ Appeal And Continues To Pursue A Mistrial
Executive Summary
Following a mammoth six-month trial, a jury in New York has issued a verdict finding that Teva and some of its affiliates are liable for the public nuisance charges made by New York state in its opioid trial in Suffolk County State Supreme Court.
You may also be interested in...
Teva’s New York Opioid Liability Climbs To $523m With Settlement Deal
Teva is on the hook to pay more than $300m to New York state over the next 18 years, in addition to $210m in damages already agreed under its proposed nationwide settlement deal, after settling claims with the New York Attorney General.
Teva Settles With San Francisco But New York Could Be Set To Prize Open Old Wounds
Teva has settled the final outstanding advanced US state-level opioid-related case against the firm, but recent allegations from the New York attorney general could see the firm back in court sooner rather than later.
Teva Puts End Of 2022 Ambition On Nationwide US Opioids Settlement
After adding more than $1bn to its legal settlement contingency in Q1, Teva has given its clearest indication yet for when it expects to announce a nationwide deal in the US to settle opioid-related claims. The Israeli firm is facing two bench trials in the coming weeks and months but is optimistic on that front also.